P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
TXG | N/A | N/A | N/A | +90.17% |
TXG Peer | N/A | N/A | N/A | -57.61% |
Biotechnology Industry | 17.4 | 15.3 | 0.3 | -339.09% |
Health Technology Sector | 29.8 | 19.6 | 0.5 | -20.57% |
S&P 500 Market | 29.6 | 25.3 | 1.1 | +99.16% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.34 | -$0.20 | -$0.12 | -$0.17 |
Previous Mean | -$0.31 | -$0.20 | -$0.12 | -$0.17 |
Standard Deviation | 0.10 | 0.13 | 0.15 | 0.07 |
Low Estimate | -$0.48 | -$0.40 | -$0.42 | -$0.22 |
High Estimate | -$0.16 | $0.02 | $0.11 | -$0.09 |